I am not certain when I first ended a failed resuscitation by asking “Let’s pause for a moment of silence in honor of the passing of this soul,” but I think that it began with the 14-year-old that I knew was dead as the ambulance stretcher made the turn into the trauma room and I could see his still heart through the hole in his left chest. …
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.